Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 54Observational 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Gastrointestinal 1Classical hematology 1

Conditions

Neutropenia 2Hematologic Neoplasms 2Mycoses 1Fever 1Febrile Neutropenia 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Itraconazole × Clear all
NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

Completed
40,110 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01021683 2013-08-12

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Janssen Korea, Ltd., Korea

Completed
203 enrolled 14 charts
Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

NCT01706562 2013-02-20

A Study of Empirical Antifungal Therapy With Itraconazole

Janssen Korea, Ltd., Korea

Completed
138 enrolled
Classical hematologyOther hematologic neoplasm

Mycoses, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡